Takeda Pharmaceutical Co Ltd (TAK)
Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies
Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies
📈 **POSITIVE** • High confidence analysis (87%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business